Multiple sclerosis in Fife

Scottish Medical Journal

Volumn 43, Issue 2, 1998, Pages 44-47

  Grant, R M ^a   Carver, A D ^b,c   Sloan, R L ^b  

^a Markinch Medical Centre   (United Kingdom)

^b NHS FIFE   (United Kingdom)

^c Cameron Hospital   (United Kingdom)

Author keywords

Interferon beta 1b; Multiple sclerosis; Prevalence

Indexed keywords

INTERFERON BETA SERINE;

ADOLESCENT; ADULT; AGED; ARTICLE; DATA BASE; FEMALE; GENERAL PRACTICE; HOSPITAL DISCHARGE; HUMAN; LICENSING; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MULTIPLE SCLEROSIS; PATIENT REFERRAL; QUESTIONNAIRE; REHABILITATION CENTER; RELAPSE; REMISSION; WORKLOAD;

EID: 0031899088     PISSN: 00369330     EISSN: None     Source Type: Journal    
DOI: 10.1177/003693309804300206     Document Type: Article

References (19)

1. British Society of Rehabilitation Medicine. Multiple Sclerosis. A Working Party Report of the British Society of Rehabilitation Medicine: British Society of Rehabilitation Medicine, 1993
2. Femandez O, Luque G, San Roman C, Bravo M, Dean G. The prevalence of multiple sclerosis in the Sanitary District of Velez-Malaga, southern Spain. Neurology 1994,44:425-29
3. Warren S, Warren KG. Prevalence, incidence, and characteristics of multiple sclerosis in Westlock County, Alberta, Canada Neurology 1993;43:1760-63.
4. Rodriguez M, Siva A, Ward J, Stolp-Smith K, O'Brien P, Kurland L Impairment, disability, and handicap in multiple sclerosis: a population-based study in Olmstead County, Minnesota. Neurology 1994:44; 28-33.
5. Dean G Epidemiology: What is new and what remains to be done. In: Multiple Sclerosis Research. Proceedings of a joint conference held by the Medical Research Council and the Multiple Sclerosis Society of Great Britain and Northern Ireland. London: HMSO, 1975.
6. Roberts MHW, Spackman AJ, Mclntosh-Michaelis S, McLellan DL, Martin JP. Prevalence of multiple sclerosis in the Southampton and South West Hampshire Health District J Neurol Neurosurg Psychiat 1991;54 55-59.
7. Shepherd DI, Downie AW Prevalence of multiple sclerosis in north-east Scotland Br Med J 1978;2:314-16.
8. Allison RS. Some neurological aspects of medical geography. Proc Royal Soc Med 1963:56.71-76.
9. Mumford CJ, Fraser MB, Wood NW, Compston DAS. Multiple sclerosis in the Cambridge health district of East Anglia. J Neurol Neurosurg Psychiatry 1992,55. 877-82.
10. The IFNB Multiple Sclerosis Study Group. Interferon beta-Ib is effective in relapsing-remitting multiple sclerosis. Neurology 1993; 43: 655-61.
11. Schering GP information. Betaferon® - a significant step forward in the treatment of multiple sclerosis. (Schering Health Care Ltd., West Sussex, 1995)
12. The Registrar General. 1991 Census Scotland. (HMSO 1993).
13. Millar JHD Multiple sclerosis in Northern Ireland. In: Clifford Rose F. ed. Clinical neuroepidemiology Tunbridge Wells Pitman Medical, 1980 222-27.
14. Shepherd DI, Downie AW. A further prevalence study of multiple sclerosis in north-east Scotland J Neurol NeurosurgPsychiatry 1980;43:310-15.
15. Poskanzer DC, Preaney LB, Sheridon JL. Kondy JY. Multiple sclerosis in Orkney and Shetland Islands: epidemiology, clinical factors and methodology J Epidemiol Community Health 1980, 1980: 229-39
16. Lockyer MJ. Prevalence of multiple sclerosis in five rural Suffolk practices. Br Med J 1991;303:347-48.
17. Williams ES, Jones DR, McKeran RO. Mortality rates from multiple sclerosis: geographical and temporal varaitions revisited. J Neurol Neurosurg Psychiatry 1991,54: 104-109
18. Williams ES, McKeran RO Prevalence of multiple sclerosis in a south London borough. Br Med J 1986; 293: 237-39.
19. Phadke JG, Downie AW. Epidemiology of multiple sclerosis in the north east (Grampian Region) of Scotland-an update JEpi Comm Health 1987,41 5-13